Concepedia

Robert L. Krigel

RL

Statistics

Publications

21

Citations

1.3K

H-Index

18

Active since

1981

Affiliations

Fox Chase Cancer Center(Current)

New York University

Rush University Medical Center

Dartmouth–Hitchcock Medical Center

University of Pittsburgh Medical Center

Robert L. Krigel is an author at Fox Chase Cancer Center specializing in oncology, medicine, and cancer immunology.

Publications per year

1981–2003

21

Publications

21

Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.

G. R. Hudes, Richard E. Greenberg, Robert L. Krigel et al. · Journal of Clinical Oncology · 1992 · 256 citations

, , +16

Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.

L Laubenstein, Robert L. Krigel, Chrystia M. Odajnyk et al. · Journal of Clinical Oncology · 1984 · 176 citations

, , +10

Primary central nervous system non-hodgkin's lymphoma: Survival advantages with combined initial therapy?

Brian Patrick O’Neill, Judith R. OʼFallon, John D. Earle et al. · International Journal of Radiation Oncology*Biology*Physics · 1995 · 151 citations

, , +9

Kaposi's sarcoma: a new staging classification.

Robert L. Krigel, L Laubenstein, Franco M. Muggia · PubMed · 1983 · 136 citations

, , +16

Prognostic factors and staging classification of patients with epidemic Kaposi's sarcoma.

Abraham Chachoua, Robert L. Krigel, Francois Lafleur et al. · Journal of Clinical Oncology · 1989 · 74 citations

, , +17

1–5 of 21